ENDO 2024 Abstract Information

March 19, 2024

There is no better place to share your research than ENDO, the Endocrine Society's annual meeting. Submitting an abstract earns media coverage for your work, connects you with scientific investigators with similar interests, and helps drive patient care for the people that need us most. All accepted abstracts will also be published in a supplement to our Open Access publication, Journal of the Endocrine Society (JES) and assigned a DOI.

The ENDO 2024 Late Breaking abstract submission site is now CLOSED.
Abstracts scheduled to be presented at ENDO 2024 are available in the ENDO 2024 Web App.
Abstract decisions are now available. If you are presenting an abstract, please see your ENDO Presenter Portal to view your abstract status. Abstract presentation information is also available in the ENDO 2024 Web App.

Please note, only abstract presenting authors will be able to access the ENDO Presenter Portal to view presentation information. Presenters should contact their co-authors to share updates to their abstract submission.

If you are a presenting author and you have not received an abstract decision notification, please check your spam and junk folders. Also be sure to add the [email protected] email to your whitelist! You are also able to view your notification in your ENDO Presenter Portal.


  • Abstract submission does not automatically register you for ENDO. Presenting authors must be registered for your abstract to be included in the ENDO 2024 program.
  • Receipts for the non-refundable abstract handling fee are available within the ENDO Presenter Portal.
  • Instructions for preparing your abstraction presentation are available online.

For questions regarding your abstract, please contact [email protected].

ENDO 2024 Abstract Embargo Policy

Unless otherwise noted, all abstracts presented at ENDO must not be released to the press or the public until the date and time of presentation. For oral presentations, the abstracts are embargoed until the session begins. Abstracts presented at a news conference are embargoed until the date and time of the news conference. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO. Please visit the ENDO media resource page for more information.

Last Updated:


Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.